ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Measurement Instrument"

  • Abstract Number: 0251 • ACR Convergence 2021

    A Comparative Study of the Validity of the DAS28-ESR and JADAS-27 Disease Activity Assessment Indexes for Juvenile Idiopathic Arthritis in Transition and Adults

    Takako Miyamae1, Eiichi Tanaka1, Eisuke Inoue2, Katsunori Ikari1 and Masayoshi Harigai3, 1Tokyo Women's Medical University, Tokyo, Japan, 2Showa University, Tokyo, Japan, 3Tokyo Women's Medical University School of Medicine, Tokyo, Japan

    Background/Purpose: The 2020 Rheumatoid Arthritis Clinical Practice Guidelines by the Ministry of Health, Labour, and Welfare Research Group recommends the JADAS27 as a measure of…
  • Abstract Number: 0315 • ACR Convergence 2021

    Sjögren’s Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) as Assessments of Symptoms in Sjögren’s Syndrome: A Qualitative Exploration of Content Validity and Meaningful Change

    Samantha Wratten1, Natasha Griffiths2, Carl Cooper2, Jessica Flynn2, Rebecca Hall3, Linda Abetz-Webb2, Wolfgang Hueber4, Briana Ndife5 and Pushpendra Goswami4, 1Adelphi Values, Macclesfield, United Kingdom, 2Adelphi Values, Bollington, United Kingdom, 3Adelphi Values Ltd, Bollington, United Kingdom, 4Novartis Pharma AG, Basel, Switzerland, 5Novartis, East Hanover, NJ

    Background/Purpose: The aim of this study was to gain qualitative patient feedback on the appropriateness of two Patient Reported Outcome (PRO) measures as assessments of…
  • Abstract Number: 0316 • ACR Convergence 2021

    Exploring Alternative Responder Definitions for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) for Use in Sjögren’s Clinical Trials

    Samantha Wratten1, Linda Abetz-Webb2, Ethan Arenson2, Mike Greenwood2, Rebecca Hall3, Pip Griffiths4, Simon J Bowman5, Wolfgang Hueber6, Briana Ndife7, Daniel Kuessner6 and Pushpendra Goswami6, 1Adelphi Values, Macclesfield, United Kingdom, 2Adelphi Values, Bollington, United Kingdom, 3Adelphi Values Ltd, Bollington, United Kingdom, 4Former Adelphi Values, Bollington, United Kingdom, 5Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 6Novartis Pharma AG, Basel, Switzerland, 7Novartis, East Hanover, NJ

    Background/Purpose: Sjögren’s is a chronic autoimmune disease symptomatically characterized by dryness, pain and fatigue, which are typically assessed in clinical trials using EULAR Sjögren’s Syndrome…
  • Abstract Number: 0317 • ACR Convergence 2021

    Patient and Physician Perspectives on EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI): A Qualitative Interview Study

    Samantha Wratten1, Carl Cooper2, Jessica Flynn2, Natasha Griffiths2, Rebecca Hall3, Linda Abetz-Webb2, Simon J Bowman4, Wolfgang Hueber5, Briana Ndife6 and Pushpendra Goswami5, 1Adelphi Values, Macclesfield, United Kingdom, 2Adelphi Values, Bollington, United Kingdom, 3Adelphi Values Ltd, Bollington, United Kingdom, 4Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 5Novartis Pharma AG, Basel, Switzerland, 6Novartis, East Hanover, NJ

    Background/Purpose: The aim of this research was to gain qualitative patient and physician feedback on the EULAR Sjögren’s syndrome patient reported index (ESSPRI) and the…
  • Abstract Number: 0474 • ACR Convergence 2021

    Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients with Active Rheumatoid Arthritis

    Meriah Moore1, Beth Wallace2, Jing Song3, Lutfiyya Muhammad4, Andrew Heisler5, Daniel Clauw1, Marcy Bolster6, Wendy Marder1, Tuhina Neogi7, Alyssa Wohlfahrt8, Dorothy Dunlop9 and Yvonne Lee9, 1University of Michigan, Ann Arbor, MI, 2Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3Northwestern University, Worthington, IL, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Bronson Rheumatology Specialists, Kalamazoo, MI, 6Massachusetts General Hospital, Boston, MA, 7Boston University School of Medicine, Boston, MA, 8Tufts University School of Medicine, Boston, MA, 9Northwestern University, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) commonly demonstrate disordered pain processing, termed central sensitization (CS). CS is typically measured using quantitative sensory testing (QST), which…
  • Abstract Number: 1263 • ACR Convergence 2020

    Association of the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) and Damage Accrual in Long Standing Systemic Lupus Erythematosus

    Kaitlin Lima1, Alexandra Legge2, John Hanly2, Jungwha Lee3, Jing Song3, Anh Chung3 and Rosalind Ramsey-Goldman4, 1Northwestern University, Chicago, IL, 2Dalhousie University, Halifax, NS, Canada, 3Northwestern University, Chicago, 4Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: The Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) was recently shown to predict mortality and damage accrual in the SLICC inception cohort. The…
  • Abstract Number: 1553 • ACR Convergence 2020

    Optical Tomography Can Accurately Diagnose Lupus Arthritis

    Wei Tang1, Alessandro Marone2, Youngwan Kim2, Tommy Chen1, Cathy Guo1, Leila Khalili1, Andreas Hielscher2 and Anca Askanase3, 1Columbia University Medical Center, New York, NY, 2Columbia University, New York, NY, 3Columbia University College of Physicians & Surgeons, New York, NY

    Background/Purpose: Incapacitating inflammatory arthritis occurs in up to 88% of patients with systemic lupus erythematosus (SLE). Arthritis is present in 70-80% of lupus patients in…
  • Abstract Number: 1595 • ACR Convergence 2020

    Using Rheumatoid Arthritis Communication Tool Developed by the RISE Learning Collaborative to Promote Shared Decision-Making

    Joad Eseddi1, Puneet Bajaj2, Gabriela Schmajuk3, Jinoos Yazdany4 and Salahuddin Kazi5, 1UT Southwestern Medical Center, Dallas, TX, 2UT Southwestern, Dallas, TX, 3University of California, San Francisco, Atherton, CA, 4University of California, San Francisco, San Francisco, CA, 5Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Patient care is moving from physician directed treatment to a co-design framework that focuses on creating a partnership between patients and physicians. This new…
  • Abstract Number: 1597 • ACR Convergence 2020

    Use of a Clinical Dashboard Improves the Documentation of Disease Severity Scores and May Facilitate the Implementation of Treat to Target Therapy

    Taylor Nelson1, Gary Kunkel2 and Grant Cannon2, 1University of Utah, Salt Lake City, 2Salt Lake City VA Medical Center and University of Utah, Salt Lake City

    Background/Purpose: Rheumatoid Arthritis (RA) management guidelines recommend the collection of Disease Activity Measures (DAMs) to direct therapy as a component of a “treat-to-target” (T2T) strategy. …
  • Abstract Number: 1602 • ACR Convergence 2020

    Assessing the Psychometric Properties of a Measure of Patient Empowerment with Patients with Arthritis

    Erin Knight-Zhang1, Kathleen Carluzzo1, Karen Schifferdecker1, Emily Creek2, Rebecca Butcher1 and Guy Eakin2, 1Dartmouth College, Lebanon, NH, 2Arthritis Foundation, Atlanta, GA

    Background/Purpose: The Health Care Empowerment Questionnaire (HCEQ) was developed for use in a general sample of patients to measure individual empowerment in health care and…
  • Abstract Number: 1614 • ACR Convergence 2020

    Use of a Best Practice Alert to Encourage Transition Planning and Readiness

    Bernard Danna1, Monique Maher1, Marietta DeGuzman2, Andrea Ramirez1, Eyal Muscal2, Amanda Brown2, Martha Curry2, Maria Pereira2, M. Brad Nelson2, Pooja Patel2, Ugo Awa2, LeeGee Huang3, Blanca Sanchez-Fournier3, JaLeen Rogers3, Ariel Coleman3, Anne Dykes3, Miriah Gillispie-Taylor2 and Tiphanie Vogel4, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, 3Texas Children's Hospital, Houston, 4Baylor College of Medicine/Texas Children's Hospital, Houston, TX

    Background/Purpose: Transitioning children with chronic diseases from pediatric to adult care can be challenging. Patients are faced with the emotional shock of entering a new…
  • Abstract Number: 1790 • ACR Convergence 2020

    Association of Telomere Length and the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) in Long Standing Systemic Lupus Erythematosus

    Kaitlin Lima1, Alexandra Legge2, John Hanly2, Jungwha Lee3, Jing Song3, Anh Chung3, Carly Skamra4, QiQuan Huang1, Richard Pope5 and Rosalind Ramsey-Goldman6, 1Northwestern University, Chicago, IL, 2Dalhousie University, Halifax, NS, Canada, 3Northwestern University, Chicago, 4Northwestern University, Brookfield, IL, 5McGaw Medical Center of Northwestern University, Chicago, IL, 6Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Frailty, an emerging concept in SLE, represents an individual’s ability to respond to physiologic stress. The first lupus-specific frailty index, the SLICC-FI, was recently…
  • Abstract Number: 1886 • ACR Convergence 2020

    Measuring Physical Activity in AxSpA:Content Validity and Measurement Properties of the New AxSpA-SQUASH

    Marllies Carbo1, Davy Paap2, Fiona Maas1, Mark Siderius3, Hendrika Bootsma1, Freke Wink3, Suzanne Arends3 and Anneke Spoorenberg3, 1University Medical Centre Groningen, Groningen, Netherlands, 2, Department of Rehabilitation Medicine, University of Medical Centre Groningen, Groningen, Netherlands, 3University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands

    Background/Purpose: The ASAS-EULAR recommendations for management of axial Spondyloarthritis (axSpA) includes that patients should be encouraged to exercise. There is no validated instrument for measuring…
  • Abstract Number: 0157 • ACR Convergence 2020

    Early Arthritis Global Assesment: What Differences Exist Between Patients and Physicians?

    Cristina Valero1, Noelia Garcia1, Juan Pablo Baldivieso2, Ana Ortiz3, Sebastian Rodriguez2 and Isidoro González-Álvaro3, 1Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 2Hospital de La Princesa, Madrid, Madrid, Spain, 3Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Madrid, Spain

    Background/Purpose: In recent years there is increasing evidence of the relevance of including the assessment of the different aspects of rheumatoid arthritis (RA) from the…
  • Abstract Number: 1888 • ACR Convergence 2020

    Successful Evaluation of Spinal Mobility Measurements with the Epionics SPINE Device in Patients with Axial Spondyloarthritis Compared to Controls

    David Kiefer1, Xenofon Baraliakos2, Daniela Adolf3, Varvara Chatzistefanidi4, Ilka Schwarze5, Uwe Lange6, Jan Brandt-Jürgens7, Edgar Stemmler8, Sabine Sartingen8 and Juergen Braun9, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 3StatConsult, Magdeburg, Germany, 4Rheumazentrum Ruhrgebiet Herne, Herne, 5Rheumazentrum Leipzig, Leipzig, 6Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany, 7Rheumatologische Schwerpunktpraxis Berlin, Berlin, Germany, 8AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany, 9Rheumazentrum Ruhrgebiet and Ruhr-University, 44649 Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) comprising radiographic (r-) and non-radiographic (nr)-axSpA is often associated with loss of mobility and impaired physical function. Established assessments of spinal…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology